PMA device
Edwards Sapien Transcatheter Heart Valve and Transfemoral and Transapical Accessories
Edwards Lifesciences, LLC · Aortic Valve, Prosthesis, Percutaneously Delivered (NPT, Class III) · First FDA decision Jan 31, 2012, newest Sep 23, 2013Aortic stenosis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
10
PMA pathway
Device trials
50
Naming "Edwards Sapien"
MAUDE reports
23,519
Brand "Edwards Sapien", since 2015
PubMed studies
1,155
Mentioning "Edwards Sapien"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Edwards Sapien Transcatheter Heart Valve and Transfemoral and Transapical Accessories
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 10 decisions filed under this name.
P110021-S026 · Decided Sep 23, 2013 · 26 days after receipt · Normal 180 Day Track
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
- EDWARDS SAPIEN TRANSCATHETER HEART VALVEPMA supplement
P110021-S023 · Decided Sep 13, 2013 · 58 days after receipt · Normal 180 Day Track No User Fee
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
- EDWARDS SAPIEN TRANSCATHETER HEART VALVE AND ACCESSORIESPMA supplement
P110021-S005 · Decided Jun 11, 2013 · 179 days after receipt · Normal 180 Day Track
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
3 more FDA decisions with a free account
Older decisions: P100041-S011, P100041-S008, P100041-S002, P100041-S001
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430RUpdated Sep 23, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430NUpdated Sep 23, 2026
- Transcatheter Aortic Valve Replacement (TAVR) for Aortic Regurgitation (AR)National analysisUnder reviewCAG-00430R3Updated Sep 14, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430R2Updated Sep 10, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National determinationOn the books20.32Updated Aug 16, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Edwards Sapien", any status and sponsor, newest update first.
- ALTERRA: SAPIEN 3 THV With the Alterra Adaptive PrestentActive, not recruiting
Edwards LifesciencesPublic (EW)
NCT03130777 · 86 participants · Start Aug 22, 2017 · Primary completion Jul 14, 2022
Device: Edwards Alterra Adaptive Prestent with SAPIEN 3 THV · For: Pulmonary Disease; Transcatheter Pulmonary Valve Replacement (TPVR); Tetralogy of Fallot and 2 more
Sites: Los Angeles, California; San Francisco, California; Aurora, Colorado · 14 sites in all
- Balloon vs. Self Expanding Transcatheter Valve for Degenerated BioprosthesisPivotal-lookingRecruiting
Erasmus Medical CenterAcademic, hospital or other
NCT04843072 · 600 participants (planned) · Start May 1, 2021 · Primary completion Jun 1, 2028
Device: EVOLUT R/PRO/PRO+/FX bioprosthesis; Edwards Sapien S3/Ultra bioprosthesis and 1 more · For: Valve Heart Disease
Sites: Los Angeles, California; Vienna, Austria; Vancouver, Canada · 14 sites in all
- ALTERRA Post-Approval StudyActive, not recruiting
Edwards LifesciencesPublic (EW)
NCT05378386 · 150 participants · Start May 12, 2022 · Primary completion Sep 25, 2025
Device: Edwards Alterra Adaptive Prestent with SAPIEN 3 Transcatheter Pulmonary Valve System · For: Pulmonary Valve Insufficiency; Complex Congenital Heart Defect; Tetralogy of Fallot and 2 more
Sites: Birmingham, Alabama; Little Rock, Arkansas; Los Angeles, California · 24 sites in all
47 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Edwards Sapien", and for the whole product code for context.
This brand
23,519 reports: 997 malfunction, 20,165 injury, 2,352 death
Whole product code NPT
77,669 reports: 12,243 malfunction, 57,723 injury, 7,693 death
Newest reports for this brand
2015691-2026-19833 · Received Oct 29, 2026
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2015691-2026-19836 · Received Oct 29, 2026 · Event dated Oct 5, 2026
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Device problem as coded: Intravalvular regurgitation
Patient problem as coded: Dyspnea; Fatigue; Heart Failure/Congestive Heart Failure
2015691-2026-19840 · Received Oct 29, 2026 · Event dated Aug 12, 2026
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0918-2014 · Started Jan 20, 2014 · Posted by FDA Feb 3, 2014
Reason given: Edwards Lifesciences is recalling two lot numbers of the 26mm transcatheter heart valve crimper because they may not open sufficiently when the handle is rotated in the full open position. As a result, user may have difficulty fitting a 26mm Sapien transcatheter heart valve into the crimper orifice when preparing the...
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Z-1134-2013 · Started Mar 26, 2013 · Posted by FDA Apr 17, 2013
Reason given: Holes in the sterile barrier pouch may be caused by handling of the device during manufacturing or once pouches have been removed from the unit box and stored on the shelf by customers.
Cause as FDA categorized it: Package design/selection · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Z-1135-2013 · Started Mar 26, 2013 · Posted by FDA Apr 17, 2013
Reason given: Holes in the sterile barrier pouch may be caused by handling of the device during manufacturing or once pouches have been removed from the unit box and stored on the shelf by customers.
Cause as FDA categorized it: Package design/selection · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Published research
The most relevant PubMed records for "Edwards Sapien"[tiab]. The summary above synthesizes these.
- Percutaneous Pulmonary Valve Implantation.
Giugno L, Faccini A, Carminati M · Korean Circ J · 2020Review
- Transcatheter Aortic Valve Implantation.
Malaisrie SC, Iddriss A, Flaherty JD, et al. · Curr Atheroscler Rep · 2016Review
- Simultaneous Stenting With Edwards SAPIEN Transcatheter Pulmonary Valve Replacement.
Heibel J, Reeves R, Alshawabkeh L, et al. · J Soc Cardiovasc Angiogr Interv · 2023
- Trans-apical systemic tricuspid valve-in-ring replacement.
Ghobrial J, Reemtsen B, Levi DS, et al. · Catheter Cardiovasc Interv · 2019Case Reports, Video-Audio Media
- Restoration of a Stuck Leaflet.
Tomarelli E, Di Pietro G, Sardella G, et al. · Catheter Cardiovasc Interv · 2025Case Reports, Video-Audio Media
- Edwards SAPIEN 3 valve.
Binder RK, Rodés-Cabau J, Wood DA, et al. · EuroIntervention · 2012
- Balloon rupture during transcatheter aortic valve replacement.
Basman C, Landers D, Kliger C, et al. · Catheter Cardiovasc Interv · 2024Review
- Transcatheter Valve-in-Valve: A Cautionary Tale.
Luc JGY, Shanks M, Tyrrell BD, et al. · Ann Thorac Surg · 2016Case Reports
- Current and future transcatheter aortic valve replacement valves.
Eikelboom R, Moran RM, Yan W, et al. · Curr Opin Cardiol · 2022Research Support, Non-U.S. Gov't, Review
- The Edwards SAPIEN Valve in the Pulmonic Position: The Not-So-New Kid on the Block.
Zahn EM · JACC Cardiovasc Interv · 2018Editorial, Comment
- Clinical studies assessing transcatheter aortic valve replacement.
Raheem S, Popma JJ · Methodist Debakey Cardiovasc J · 2012Research Support, Non-U.S. Gov't, Review
- Performance of the Edwards Sapien 3 bioprosthesis in atrioventricular valve position: a case series.
Garretano A, Abella R, Doblas JF, et al. · Eur Heart J Case Rep · 2024Case Reports
Other devices of this type
Also filed under product code NPT.
- Sapien 3 Transcatheter Heart Valve and AccessoriesEdwards Lifesciences, LLC · PMA 2025
- Medtronic CoreValve Evolut R SystemMedtronic, Inc. · PMA 2022
- Edwards SAPIEN XT Transcatheter Heart ValveEdwards Lifesciences, LLC · PMA 2020
- Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart ValveEdwards Lifesciences, LLC · PMA 2026
- Medtronic CoreValve SystemMedtronic, Inc. · PMA 2023
- Navitor Transcatheter Aortic Valve Implantation SystemAbbott Medical · PMA 2026
- Trilogy Transcatheter Heart Valve SystemJenaValve Technology, Inc. · PMA 2026
- LOTUS Edge Valve SystemBoston Scientific Corporation · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.